Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
Under the Spotlight: Agentic AI
In an interview with Pharmaceutical Outsourcing, ArisGlobal’s Jason Bryant discusses the premise of AI’s next high-profile incarnation, the technology’s potential in late-stage pharma R&D operations, emerging early use cases, and some of the guardrails that need to be in place to ensure trusted, impactful use. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Cellipont Bioservices Announces Release of 100th GMP Batch
Thursday, July 30, 2026
Cellipont Bioservices announced the successful release of its 100th GMP batch at its manufacturing facility in The Woodlands, Texas. read more
Piramal Pharma Starts FY27 With 17% Revenue Growth, Higher EBITDA
Thursday, July 30, 2026
Piramal Pharma said it began FY27 with stronger revenue and margin expansion, driven by broad-based growth across its contract development and ... read more
Harbour BioMed, Sinopharm Form R&D Consortium for Innovative Biologics
Wednesday, July 29, 2026
Harbour BioMed and China National Pharmaceutical Group announced a strategic collaboration to establish a joint innovation R&D consortium focused on ... read more
AsymBio Breaks Ground on Fengxian R&D Building to Expand Biologics Services
Wednesday, July 29, 2026
AsymBio has begun construction of a new R&D building at its Shanghai Fengxian site, a move the company said will strengthen its biologics CDMO ... read more
ICON, Anthropic Launch Multi-Year AI Collaboration for Clinical Trials
Tuesday, July 28, 2026
ICON has announced a multi-year collaboration with Anthropic to bring Claude’s AI capabilities across the clinical trial lifecycle, expanding the ... read more